No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

The gene RAD51C is a “cancer protection” gene that encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast ...

New research identifies specific genetic changes that can increase a person's risk of breast and ovarian cancers, to help guide clinical decision-making. Scientists have pinpointed thousands of ...

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the 'cancer protection' gene RAD51C, finding over 3,000 harmful genetic changes that could potentially disrupt its ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, finding over 3,000 harmful genetic changes that could potentially disrupt ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, known to increase ovarian cancer risk six-fold and risk of aggressive subtypes of ...

Offering a two-in-one approach to delivering targeted therapeutics to patients and providing a versatile solution to the challenges associated with the co-administration of drugs, bispecific ...

With a focus on the "cancer protection" gene RAD51C, researchers from the Wellcome Sanger Institute and their partners discovered over 3,000 deleterious genetic alterations that may interfere with its ...